Related Experiment Video
Updated: Oct 17, 2026

A Simplified Protocol for Protecting Palatal Soft Tissue Donor Sites Using an Oral Mucoadhesive Bandage
Published on: February 17, 2026
Nanoparticle-incorporated bilayer tamarind seed polysaccharide/pullulan films with sustained mucoadhesion for oral
Suping Ji1, Yingying Shao2, Wenjuan Wang3
1School of Biological Science and Medical Engineering, State Key Laboratory of Digital Medical Engineering, Southeast University, Nanjing, 210096, China; College of Food Science and Technology, Zhejiang Pharmaceutical University, Ningbo, 315000, China; Collaborative Innovation Center of Suzhou Nano Science and Technology, Suzhou, 215123, China.
Abstract:
The low drug loading capacity of oral films critically restricts their therapeutic potential, posing a primary limitation to their broader applicability. To improve the loading and delivery efficiency of oral films, bilayer films were developed, consisting of a mucoadhesive pullulan layer loaded with resveratrol-bovine serum albumin nanoparticles (Res-BSA) and a hydrophobic backing layer based on tamarind seed polysaccharide. The content of Res-BSA in the bilayer film was enhanced by increasing Res-BSA concentration (0-50%) in the mucoadhesive layer or by augmenting the mucoadhesive layer content at a fixed Res-BSA concentration (20%). The effects of increased Res-BSA content on the mechanical properties of the bilayer film could be mitigated by the backing layer, thereby preserving its flexibility. Resveratrol was continuously released from the bilayer films containing Res-BSA for over 12 h, demonstrating good antibacterial activity. The bilayer film containing 20% Res-BSA (TSP/Pul-1:1-20%) was effective in promoting cell migration and could provide a protective barrier for the oral mucosa through its sustained mucoadhesion (lasting over 12 h in vivo). In the rat oral ulcer model, TSP/Pul-1:1-20% accelerated ulcer healing by promoting re-epithelialization, increasing collagen deposition, and reducing inflammation. Additionally, TSP/Pul-1:1-20% may modulate the oral microbiota, partially shifting its composition toward a normal-like state. These results demonstrated that the bilayer films containing Res-BSA could be a promising platform for local oral treatment or transmucosal drug delivery.
Related Concept Videos
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Oral Drug Delivery Systems: Delayed-Release Systems
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
